2. Hennessy S, Strom BL, Lipton HL, Soumerai SB. In: Storm BL, editor. Drug utilization review. Pharmacoepidemiology 2000;3rd ed. Chichester: John Wiley & Sons, LtD. 505-523.
3. Lee D, Bergman U. In: Storm BL, editor. Studies of drug utilization. Pharmacoepidemiology 2000;3rd ed. Chichester: John Wiley & Sons, LtD. 463-481.
4. Moore WJ, Gutermuth K, Pracht EE. Systemwide effects of Medicaid retrospective drug utilization review programs. J Health Polit Policy Law 2000;25:653-688.
5. Kidder D, Bae J. Evaluation results from prospective drug utilization review: Medicaid demonstrations. Health Care Financ Rev 1999;20:107-118.
6. Soumerai SB, Lipton HL. Computer-based drug-utilization review-risk, benefit, or boondoggle? NEJM 1995;332:1641-1645.
7. Holm RP, Helgeland D. DEEP, South Dakota Medicaid drug use review program. Is the hassle justified? SDJ Med 1993;46:368-369.
8. Guo JJ, Gibson JT, Hancock GR, Barker KN. Retrospective drug utilization review and the behavior of Medicaid prescribers:an empirical marginal analysis. Clin Ther 1995;17:1174-1187.
10. Sacristan JA, Soto J. Drug utilization studies as tools in health economics. Pharmacoeconomics 1994;5:299-312.
11. American Pain Society. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. Glenview 2002;43-117.